Inflammasome Activation in Chronic Glomerular Diseases.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Current Drug Targets

• Publication date

  2017-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1389450117666160817103435PMID 27538510PMCID PMC5893309
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular Pathobiology of Inflammasomes: Inflammatory Machinery and Beyond

  2015cited by this paper
• NADPH Oxidase-Induced NALP3 Inflammasome Activation Is Driven by Thioredoxin-Interacting Protein Which Contributes to Podocyte Injury in Hyperglycemia

  2015cited by this paper
• Albumin impairs renal tubular tight junctions via targeting the NLRP3 inflammasome.

  2015cited by this paper
• Involvement of endoplasmic reticulum stress in angiotensin II-induced NLRP3 inflammasome activation in human renal proximal tubular cells in vitro

  2015cited by this paper
• Molecular Activation of the NLRP3 Inflammasome in Fibrosis: Common Threads Linking Divergent Fibrogenic Diseases

  2015cited by this paper
• Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.

  2015cited by this paper
• Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy

  2014cited by this paper
• Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis.

  2014cited by this paper
• Contribution of endogenously produced reactive oxygen species to the activation of podocyte NLRP3 inflammasomes in hyperhomocysteinemia.

  2014cited by this paper
• New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease.

  2014cited by this paper
• The NLRP3/ASC inflammasome promotes T-cell-dependent immune complex glomerulonephritis by canonical and noncanonical mechanisms.

  2014cited by this paper
• Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin.

  2014cited by this paper
• Activation of inflammasomes in podocyte injury of mice on the high fat diet: Effects of ASC gene deletion and silencing.

  2014cited by this paper
• Is the inflammasome a potential therapeutic target in renal disease?

  2014cited by this paper
• Molecular mechanisms of diabetic kidney disease.

  2014cited by this paper
• Nod-like Receptor Protein 3 (NLRP3) Inflammasome Activation and Podocyte Injury via Thioredoxin-Interacting Protein (TXNIP) during Hyperhomocysteinemia*

  2014cited by this paper
• Regulation of TLR2 and NLRP3 in Primary Murine Renal Tubular Epithelial Cells

  2014cited by this paper
• Activation of Nlrp3 Inflammasomes Enhances Macrophage Lipid-Deposition and Migration: Implication of a Novel Role of Inflammasome in Atherogenesis

  2014cited by this paper
• IL–1β and IL–18: inflammatory markers or mediators of hypertension?

  2014cited by this paper
• NADPH Oxidase-Mediated Triggering of Inflammasome Activation in Mouse Podocytes and Glomeruli During Hyperhomocysteinemia

  2013cited by this paper
• Bay11-7082 attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.

  2013cited by this paper
• C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation.

  2013cited by this paper
• Activation and regulation of the inflammasomes

  2013influential reference
• Novel drugs and intervention strategies for the treatment of chronic kidney disease

  2013cited by this paper
• TLR-independent and P2X7-dependent signaling mediate Alu RNA-induced NLRP3 inflammasome activation in geographic atrophy.

  2013cited by this paper
• Activation of Nod-Like Receptor Protein 3 Inflammasomes Turns on Podocyte Injury and Glomerular Sclerosis in Hyperhomocysteinemia

  2012cited by this paper
• NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice

  2012cited by this paper
• Ventilator-induced Lung Injury Is Mediated by the NLRP3 Inflammasome

  2012cited by this paper
• Inflammasome activators induce interleukin-1α secretion via distinct pathways with differential requirement for the protease function of caspase-1.

  2012cited by this paper
• Caspase-1: is IL-1 just the tip of the ICEberg?

  2012cited by this paper
• NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223

  2012cited by this paper
• Instigation of NLRP3 inflammasome activation and glomerular injury in mice on the high fat diet: role of acid sphingomyelinase gene

  2012cited by this paper
• This information is current as Production β Inflammasome and IL-1 miR-BART 15 Regulate the NLRP 3 Cutting Edge : miR-223 and EBV

  2012cited by this paper
• Emerging inflammasome effector mechanisms

  2011influential reference
• Monocyte/macrophage chemokine receptor CCR2 mediates diabetic renal injury.

  2011cited by this paper
• IL-1 (cid:1) Receptor Antagonist Reduces Inflammation in Hemodialysis Patients

  2011cited by this paper
• Faculty Opinions recommendation of Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity.

  2011cited by this paper
• Innate immune recognition of bacterial ligands by NAIPs dictates inflammasome specificity

  2011cited by this paper
• The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus

  2011cited by this paper
• IL-1β receptor antagonist reduces inflammation in hemodialysis patients.

  2011cited by this paper
• Scope and mechanisms of obesity-related renal disease

  2010cited by this paper
• Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome.

  2010cited by this paper
• Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells.

  2010cited by this paper
• The NLRP3 Inflammasome: A Sensor for Metabolic Danger?

  2010cited by this paper
• NLRP3 inflamasomes are required for atherogenesis and activated by cholesterol crystals that form early in disease

  2010cited by this paper
• Pattern recognition receptors and inflammation.

  2010cited by this paper
• Thioredoxin-interacting protein links oxidative stress to inflammasome activation

  2010cited by this paper
• The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance

  2010cited by this paper
• NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

  2010cited by this paper
• Autoimmune kidney diseases.

  2010cited by this paper
• NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?

  2010cited by this paper
• Endothelial dysfunction is associated with increased levels of biomarkers in essential hypertension

  2010cited by this paper
• Molecular Mechanism of NLRP3 Inflammasome Activation

  2010cited by this paper
• Sterile inflammatory responses mediated by the NLRP3 inflammasome

  2010cited by this paper
• Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome

  2010cited by this paper
• The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study

  2009cited by this paper
• Inflammasome recognition of influenza virus is essential for adaptive immune responses

  2009cited by this paper
• Contribution of Guanine Nucleotide Exchange Factor Vav2 to Hyperhomocysteinemic Glomerulosclerosis in Rats

  2009cited by this paper
• Cutting Edge: Candida albicans Hyphae Formation Triggers Activation of the Nlrp3 Inflammasome1

  2009cited by this paper
• Cutting Edge: TNF-α Mediates Sensitization to ATP and Silica via the NLRP3 Inflammasome in the Absence of Microbial Stimulation1

  2009cited by this paper
• The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1.

  2009cited by this paper
• Mechanisms of regulated unconventional protein secretion

  2009cited by this paper
• Glyburide inhibits the Cryopyrin/Nalp3 inflammasome

  2009cited by this paper
• Malarial Hemozoin Is a Nalp3 Inflammasome Activating Danger Signal

  2009cited by this paper
• Immunological and inflammatory functions of the interleukin-1 family.

  2009cited by this paper
• Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors

  2009cited by this paper
• Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence

  2009cited by this paper
• Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).

  2009cited by this paper
• NLRP3/Cryopyrin Is Necessary for Interleukin-1β (IL-1β) Release in Response to Hyaluronan, an Endogenous Trigger of Inflammation in Response to Injury*

  2009cited by this paper
• Neisseria gonorrhoeae Activates the Proteinase Cathepsin B to Mediate the Signaling Activities of the NLRP3 and ASC-Containing Inflammasome1

  2009cited by this paper
• Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica

  2008cited by this paper
• Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

  2008cited by this paper
• Homocysteine Induces Monocyte Chemoattractant Protein-1 Expression in Hepatocytes Mediated via Activator Protein-1 Activation*

  2008cited by this paper
• The NALP3 inflammasome is involved in the innate immune response to amyloid-β

  2008cited by this paper
• Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

  2008cited by this paper
• Successful treatment of resistant pseudogout with anakinra.

  2008cited by this paper
• Homocysteine stimulates monocyte chemoattractant protein-1 expression in mesangial cells via NF-kappaB activation.

  2008cited by this paper
• Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

  2008cited by this paper
• The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response

  2008cited by this paper
• Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation.

  2007influential reference
• Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration

  2007cited by this paper
• Cryopyrin activates the inflammasome in response to toxins and ATP

  2006cited by this paper
• Inhibition of ceramide-redox signaling pathway blocks glomerular injury in hyperhomocysteinemic rats.

  2006influential reference
• TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity.

  2006cited by this paper
• Gout-associated uric acid crystals activate the NALP3 inflammasome

  2006cited by this paper
• Adipose tissue and inflammation in chronic kidney disease.

  2006cited by this paper
• Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor

  2006cited by this paper
• Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin

  2006influential reference
• ATP-sensitive potassium channelopathies: focus on insulin secretion.

  2005cited by this paper
• Differing caspase‐1 activation states in monocyte versus macrophage models of IL‐1β processing and release

  2004cited by this paper
• Bi-directional protein transport between the ER and Golgi.

  2004cited by this paper
• NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder.

  2004cited by this paper
• Is obesity a major cause of chronic kidney disease?

  2004cited by this paper
• Activation of mesangial cell MAPK in response to homocysteine.

  2004cited by this paper
• Quality control and protein folding in the secretory pathway.

  2003cited by this paper
• Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents.

  2002cited by this paper
• Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents.

  2002cited by this paper
• The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta.

  2002cited by this paper
• Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis.

  2002cited by this paper
• Inhibition of ATP-binding cassette transporter downregulates interleukin-1beta-mediated autocrine activation of human dermal fibroblasts.

  2001cited by this paper

• The lipid–podocyte axis: emerging clues in membranous nephropathy pathogenesis

  2026cites this paper
• Mitochondrial Derived Peptides (MDPs) as Emerging Gero Protectors: Molecular Signaling, Systemic Effects, and Translational Perspectives

  2025cites this paper
• Uric Acid and Preeclampsia: Pathophysiological Interactions and the Emerging Role of Inflammasome Activation

  2025cites this paper
• Cathepsin B-dependent glycolysis contributes to reduced renal uric acid excretion in hyperuricemia

  2025cites this paper
• Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation

  2024cites this paper
• [Progress of experimental research on the underlying mechanisms of acupuncture in improving chronic obstructive pulmonary disease].

  2024cites this paper
• Podocyte-Specific Silencing of Acid Sphingomyelinase Gene to Abrogate Hyperhomocysteinemia-Induced NLRP3 Inflammasome Activation and Glomerular Inflammation.

  2024cites this paper
• Puerarin alleviates diabetic nephropathy by inhibiting Caspase-1-mediated pyroptosis.

  2024cites this paper
• Glomerular-tubular crosstalk via cold shock Y-box binding protein-1 in the kidney.

  2023cites this paper
• Anti-inflammatory effects of acupuncture in the treatment of chronic obstructive pulmonary disease.

  2023cites this paper
• Interplay of lipid metabolism and inflammation in podocyte injury.

  2023cites this paper
• Identifying Aging-Related Biomarkers and Immune Infiltration Features in Diabetic Nephropathy Using Integrative Bioinformatics Approaches and Machine-Learning Strategies

  2023cites this paper
• Role of the NLRP3 inflammasome in gynecological disease.

  2023cites this paper
• Inhibiting NLRP3 signaling in aging podocytes improves their life- and health-span

  2023cites this paper
• Identification of Rab7 as an autophagy marker: potential therapeutic approaches and the effect of Qi Teng Xiao Zhuo granule in chronic glomerulonephritis

  2023cites this paper
• Astragaloside IV Attenuates High-Glucose-Induced Impairment in Diabetic Nephropathy by Increasing Klotho Expression via the NF-κB/NLRP3 Axis

  2023cites this paper
• Metabolic Dysfunction in the Regulation of the NLRP3 Inflammasome Activation: A Potential Target for Diabetic Nephropathy

  2022cites this paper
• Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I.

  2022cites this paper
• Identifying effective diagnostic biomarkers and immune infiltration features in chronic kidney disease by bioinformatics and validation

  2022cites this paper
• Insight into the regulation of NLRP3 inflammasome activation by mitochondria in liver injury and the protective role of natural products.

  2022cites this paper
• Ferulic acid ameliorates renal injury via improving autophagy to inhibit inflammation in diabetic nephropathy mice.

  2022cites this paper
• Sinomenine alleviates glomerular endothelial permeability by activating the C/EBP-α/claudin-5 signaling pathway

  2022cites this paper
• Release and Actions of Inflammatory Exosomes in Pulmonary Emphysema: Potential Therapeutic Target of Acupuncture

  2021cites this paper
• NLRP3 Inflammasome at the Interface of Inflammation, Endothelial Dysfunction, and Type 2 Diabetes

  2021cites this paper
• Contribution of Podocyte inflammatory exosome release to glomerular inflammation and sclerosis during Hyperhomocysteinemia.

  2021cites this paper
• SIRT1 Alleviates Aldosterone-Induced Podocyte Injury by Suppressing Mitochondrial Dysfunction and NLRP3 Inflammasome Activation

  2021cites this paper
• Caspase-1-Inhibitor AC-YVAD-CMK Inhibits Pyroptosis and Ameliorates Acute Kidney Injury in a Model of Sepsis

  2021cites this paper
• Hyperuricemia, Elevated Body Mass Index, Female Sex, and Albuminuria Increase the Probability of Elevated High-Sensitivity C-Reactive Protein: Results From the National Health and Nutrition Examination Survey 2015–2018

  2021cites this paper
• Mechanisms of Kidney Cell Pyroptosis in Chronic Kidney Disease and the Effects of Traditional Chinese Medicine

  2021cites this paper
• Interplay of immune and kidney resident cells in the formation of tertiary lymphoid structures in lupus nephritis.

  2021cites this paper
• Behind every smile there's teeth: Cathepsin B's function in health and disease with a kidney view.

  2021cites this paper
• HMGB1 mediates homocysteine-induced endothelial cells pyroptosis via cathepsin V-dependent pathway.

  2020cites this paper
• Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid‐resistant from glucocorticoid‐sensitive idiopathic nephrotic syndrome patients

  2020cites this paper
• LCC18, a benzamide‐linked small molecule, ameliorates IgA nephropathy in mice

  2020cites this paper
• The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

  2020cites this paper
• Long non-coding RNA Kcnq1ot1 promotes sC5b-9-induced podocyte pyroptosis by inhibiting miR-486a-3p and upregulating NLRP3.

  2020cites this paper
• Associations between the concentrations of CD68, TGF-β1, renal injury index and prognosis in glomerular diseases

  2020cites this paper
• Lysosomal regulation of extracellular vesicle excretion during D-ribose-induced NLRP3 inflammasome activation in podocytes

  2019cites this paper
• Urinary peptidomics in early type 1 diabetes Title: Peptidomic analysis of urine from youths with early type 1 diabetes reveals novel bioactivity of uromodulin peptides in vitro

  2019cites this paper
• Role of NLRP3 inflammasome in the development of bladder pain syndrome interstitial cystitis

  2019cites this paper
• A Pilot Study Comparing Uric Acid and Biomarkers of Renal Injury and Inflammation in Pediatric Sickle Cell Disease at Vaso-Occlusive Crisis and Steady State

  2019cites this paper
• Peptidomic Analysis of Urine from Youths with Early Type 1 Diabetes Reveals Novel Bioactivity of Uromodulin Peptides In Vitro*

  2019cites this paper
• Role of Inflammasome in Chronic Kidney Disease.

  2019cites this paper
• Rac1 GTPase Inhibition Blocked Podocyte Injury and Glomerular Sclerosis during Hyperhomocysteinemia via Suppression of Nucleotide-Binding Oligomerization Domain-Like Receptor Containing Pyrin Domain 3 Inflammasome Activation

  2019cites this paper
• Sphingolipids and Redox Signaling in Renal Regulation and Chronic Kidney Diseases

  2018cites this paper
• Toxicity of environmental nanosilver: mechanism and assessment

  2018cites this paper
• A New Participant in the Pathogenesis of Alcoholic Gastritis: Pyroptosis

  2018cites this paper
• Integrative Bioinformatics Analysis Provides Insight into the Molecular Mechanisms of Chronic Kidney Disease

  2018cites this paper
• IL-1β increases urinary corin in patients with primary proteinuric kidney diseases and in 293 cells.

  2017cites this paper
• The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease

  2017influential citation
• Inflammasomes, the cardinal pathology mediators are activated by pathogens, allergens and mutagens: A critical review with focus on NLRP3.

  2017cites this paper
• Low-dose Sinapic Acid Abates the Pyroptosis of Macrophages by Downregulation of lncRNA-MALAT1 in Rats With Diabetic Atherosclerosis

  2017cites this paper
• Inflammasomes and Natural Ingredients towards New Anti-Inflammatory Agents

  2016cites this paper